SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Nereus is focusing on the oceans and marine environments as a source of small-molecule compounds for the treatment of inflammation, cancer, and infectious diseases. Nereus utilized specialized research out of the Scripps Institution of Oceanography.
Nereus
San Diego, CA
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.